Congrats to Dr. Andrew Reisner and his colleagues at Children's and Emory on this exciting discovery! We love seeing this kind of collaboration from our investigators!
Exciting news: A recent pilot study, led by our very own Dr. Andrew Reisner, showed evidence for a blood indicator in kids who may have worse COVID-19 and MIS-C symptoms than others. In collaboration with infectious disease experts at Children’s, our pediatric neurotrauma team discovered elevated levels of plasma osteopontin, an inflammatory biomarker they used to follow traumatic brain injuries (TBI) and concussions, were also elevated in COVID-19 positive and MIS-C patients. The findings were just published in Experimental Biology and Medicine, and the research team, including Drs. Laura Blackwell, Evan Anderson, Andi Shane and Christina Rostad, are hopeful results will be confirmed in a full clinical trial, allowing clinicians to measure osteopontin to direct the course of treatment, and likely better outcomes, for those diseases. https://www.choa.org/biomarkerstudy